ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 192 filers reported holding ARCUS BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $24,551,933 | 27.51% |
| Decheng Capital LLC | 869,790 | $13,246,902 | 4.06% |
| Boxer Capital, LLC | 1,602,200 | $24,401,506 | 1.28% |
| DAFNA Capital Management LLC | 253,217 | $3,856,495 | 0.92% |
| Parkman Healthcare Partners LLC | 415,535 | $6,328,598 | 0.85% |
| Woodline Partners LP | 4,245,221 | $64,654,716 | 0.62% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 957,304 | $14,579,740 | 0.54% |
| SECTORAL ASSET MANAGEMENT INC | 78,385 | $1,193,804 | 0.48% |
| Ikarian Capital, LLC | 145,000 | $2,208,350 | 0.38% |
| Granahan Investment Management | 379,847 | $5,785,070 | 0.23% |
| Seelaus Asset Management LLC | 13,000 | $197,990 | 0.20% |
| Corton Capital Inc. | 24,221 | $368,886 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 159,108 | $2,423 | 0.17% |
| EntryPoint Capital, LLC | 5,004 | $76,211 | 0.11% |
| Bridgefront Capital, LLC | 16,721 | $254,661 | 0.11% |
| PDT Partners, LLC | 73,265 | $1,115,826 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 153,783 | $2,342,115 | 0.10% |
| Pennant Investors, LP | 23,700 | $360,951 | 0.09% |
| Spartan Fund Management Inc. | 2,000 | $30,460 | 0.09% |
| Point72 Asia (Singapore) Pte. Ltd. | 26,677 | $406,291 | 0.08% |
External links
This page lists ARCUS BIOSCIENCES INC's shareholders in Q2 2024. To view ARCUS BIOSCIENCES INC's shareholder history, click here.